Enveric Biosciences Faces Delisting Notice
Ticker: ENVB · Form: 8-K · Filed: Aug 29, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $2,500,000, $2,184,769, $35 m, $500,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Enveric Biosciences got a notice about potentially being delisted. Uh oh.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on August 26, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, previously known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC, is incorporated in Delaware and headquartered in Naples, Florida.
Why It Matters
This filing indicates potential issues with Enveric Biosciences' continued listing on a stock exchange, which could impact its stock price and trading accessibility.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial health.
Key Numbers
- 001-38286 — SEC File Number (Identifies the company's filing history with the SEC.)
- 95-4484725 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- AMERI Holdings, Inc. (company) — Former Company Name
- SPATIALIZER AUDIO LABORATORIES INC (company) — Former Company Name
- August 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Naples, FL (location) — Principal executive offices
FAQ
What specific listing rule or standard did Enveric Biosciences fail to satisfy?
The filing does not specify the exact rule or standard that Enveric Biosciences failed to satisfy, only that a notice has been received.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is August 26, 2025.
What is Enveric Biosciences' principal executive office address?
The principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What were Enveric Biosciences' former company names?
Enveric Biosciences, Inc. was formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC.
What is the SEC file number for Enveric Biosciences?
The SEC file number for Enveric Biosciences is 001-38286.
Filing Stats: 917 words · 4 min read · ~3 pages · Grade level 13.5 · Accepted 2025-08-29 17:10:33
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Ma
- $2,500,000 — intain stockholders' equity of at least $2,500,000 (the "Stockholders'Equity Requirement")
- $2,184,769 — 2025, reported stockholders' equity of $2,184,769. As of the date of this Current Report
- $35 m — a market value of listed securities of $35 million, or net income from continued ope
- $500,000 — net income from continued operations of $500,000 in the most recently completed fiscal y
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001641172-25-026040.txt ( ) — 201KB
- envb-20250826.xsd (EX-101.SCH) — 3KB
- envb-20250826_lab.xml (EX-101.LAB) — 33KB
- envb-20250826_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 29, 2025 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer